Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Real-world outcomes among patients with advanced/metastatic renal cell carcinoma (mRCC) treated with tyrosine kinase inhibitors (TKls) monotherapy or TKI-IO combination therapy.

View Full Paper
Ask AI
Bookmark
Share

Authors

PDPei DongTHTingxuan HuangYPYulu Peng

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dong et al. (2024) studied this question.

synapsesocial.com/papers/68e67065b6db6435875fad9ehttps://doi.org/10.1200/jco.2024.42.16_suppl.e16514
View Full Paper
Ask AI
Bookmark
Share